{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T01:37:14Z","timestamp":1771378634252,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1992,1,1]],"date-time":"1992-01-01T00:00:00Z","timestamp":694224000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother. Pharmacol."],"published-print":{"date-parts":[[1992]]},"DOI":"10.1007\/bf00686001","type":"journal-article","created":{"date-parts":[[2004,11,29]],"date-time":"2004-11-29T08:11:43Z","timestamp":1101715903000},"page":"339-342","source":"Crossref","is-referenced-by-count":55,"title":["Penetration of etoposide into human malignant brain tumors after intravenous and oral administration"],"prefix":"10.1007","volume":"29","author":[{"given":"Katsuzo","family":"Kiya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Uozumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Ogasawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuhiro","family":"Hotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Kurisu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"49","volume":"17","author":"DN Carney","year":"1990","unstructured":"Carney DN, Grogan L, Smit EF, Harford P, Berendsen HH, Postmus PE (1990) Single-agent oral etoposide for elderly small cell lung cancer patients. Semin Oncol 17:49","journal-title":"Semin Oncol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF00254535","volume":"7","author":"PJ Creaven","year":"1982","unstructured":"Creaven PJ (1982) The clinical pharmacology of VM 26 and VP 16-213. A brief overview. Cancer Chemother Pharmacol 7:133","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR3","first-page":"69","volume":"69","author":"M D'Incalci","year":"1985","unstructured":"D'Incalci M, Sessa C, Rosso C, Roviaro G, Mangioni C (1985) Pharmacokinetics of etoposide in gestochoriocarcinoma. Cancer Treat Rep 69:69","journal-title":"Cancer Treat Rep"},{"key":"CR4","first-page":"397","volume":"4","author":"LG Feun","year":"1987","unstructured":"Feun LG, Lee Y-Y, Yung W-KA, Savaraj N, Qallace S (1987) Intracarotid VP-16 in malignant brain tumors. J Neurooncol 4:397","journal-title":"J Neurooncol"},{"key":"CR5","first-page":"603","volume":"69","author":"GP Finn","year":"1985","unstructured":"Finn GP, Bozek T, Souhami RL, Slevin ML, Thomas DGT (1985) High-dose ctoposide in the treatment of relapsed primary brain tumors. Cancer Treat Rep 69:603","journal-title":"Cancer Treat Rep"},{"key":"CR6","first-page":"759","volume":"71","author":"L Giannone","year":"1987","unstructured":"Giannone L, Wolff SN (1987) Phase II treatment of central nervous system gliomas with high-dose etoposide and autologous bone marrow transplantation. Cancer Treat Rep 71:759","journal-title":"Cancer Treat Rep"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF00163706","volume":"6","author":"H Haaxma-Reiche","year":"1988","unstructured":"Haaxma-Reiche H, Berendsen HH, Postmus PE (1988) Podophyllotoxins for brain metastases of small cell lung cancer. J Neurooncol 6:231","journal-title":"J Neurooncol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1200\/JCO.1989.7.3.396","volume":"7","author":"JD Hainsworth","year":"1989","unstructured":"Hainsworth JD, Johnson DH, Frazier SR, Greco FA (1989) Chronic daily administration of oral etoposide. A phase I trial. J Clin Oncol 7:396","journal-title":"J Clin Oncol"},{"key":"CR9","first-page":"379","volume":"44","author":"KR Hande","year":"1984","unstructured":"Hande KR, Wedlund PJ, Noone RM, Wilkinson GR, Greco FA, Wolff SN (1984) Pharmacokinetics of high-dose etoposide (VP-16-213) administration to cancer patients. Cancer Res 44:379","journal-title":"Cancer Res"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/0277-5379(86)90315-9","volume":"22","author":"JJM Holthuis","year":"1986","unstructured":"Holthuis JJM, Postmus PE, Oort WJV, Hulshoff B, Verleun H, Sleijfer DT, Mulder NH (1986) Pharmacokinetics of high dose etoposide (VP16-213). Eur J Cancer Oncol 22:1149","journal-title":"Eur J Cancer Oncol"},{"key":"CR11","first-page":"479","volume":"23","author":"G Idzu","year":"1989","unstructured":"Idzu G, Yazawa Y, Tachibana M, Terada T, Hashimoto Y, Shimazu T (1989) Determination of etoposide in plasma by high performance liquid chromatography with fluorescence detection. Clin Rep 23:479","journal-title":"Clin Rep"},{"key":"CR12","first-page":"631","volume":"74","author":"JPP Kleisbauer","year":"1987","unstructured":"Kleisbauer JPP, Lena-Nosny N, Vesco D (1987) Taux seriques dans le liquide cephalo-rachidien apres forte dose d'etopside administree par voie intraveineuse. Bull Cancer 74:631","journal-title":"Bull Cancer"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0277-5379(88)90243-X","volume":"24","author":"JP Kleisbauer","year":"1988","unstructured":"Kleisbauer JP, Vesco D, Orehek J, Blaive B, Clary C, Poirier R, Saretto S, Carles P, Dongay G, Guerin JC, Martinat Y (1988) Treatment of brain metastases of lung cancer with high doses of etoposide (VP16-213). Cooperative study of the Groupe Fran\u00e7ais Pneumo Canc\u00e9rologie. Eur J Cancer Oncol 24:131","journal-title":"Eur J Cancer Oncol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3171\/jns.1989.70.5.0676","volume":"70","author":"T Kobayashi","year":"1989","unstructured":"Kobayashi T, Yoshida J, Ishiyama J, Noda S, Kito A, Kida Y (1989) Combination chemotherapy with cisplatin and etoposide for malignant intracranial germ-cell tumors. An experimental and clinical study. J Neurosurg 70:676","journal-title":"J Neurosurg"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1200\/JCO.1989.7.7.916","volume":"7","author":"SJ Lee","year":"1989","unstructured":"Lee SJ, Murphy WK, Glisson BS, Dhinga HM, Holoye PY, Hong WK (1989) Primary chemotherapy of brain metastasis in small-cell lung cancer. J Clin Oncol 7:916","journal-title":"J Clin Oncol"},{"key":"CR16","first-page":"245","volume":"31","author":"K Lu","year":"1982","unstructured":"Lu K, Savraj N, Feun L, Leaven M, Loo TL (1982) Clinical pharmacology and intracerebral tumor penetration of 4?-demethyl epipodophyllotoxin 9-(4,6-O-ethylidene-?-d-glucopyranoside) (VP-16, NSC-141 540). Clin Pharmacol Ther 31:245","journal-title":"Clin Pharmacol Ther"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1200\/JCO.1984.2.3.215","volume":"2","author":"PE Postmus","year":"1984","unstructured":"Postmus PE, Holthuis JJM, Haaxma-Reiche H, Mulder NH, Vencken LM, Oort WJ, Sleijfer DT, Sluiter HJ (1984) Penetration of VP16-213 into cerebrospinal fluid after high-dose intravenous administration. J Clin Oncol 2:215","journal-title":"J Clin Oncol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/bjc.1989.52","volume":"59","author":"PE Postmus","year":"1989","unstructured":"Postmus PE, Haaxma-Reiche H, Sleijfer DT, Kirkpatriek A, McVie JG, Kleisbauer JP, for the EORTC Lung Cooperative Group (1989) High dose etoposide for brain metastasis of small cell lung cancer. A phase II study. Br J Cancer 59:254","journal-title":"Br J Cancer"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/1097-0142(19910101)67:1+<319::AID-CNCR2820671319>3.0.CO;2-D","volume":"67","author":"ML Slevin","year":"1991","unstructured":"Slevin ML (1991) The clinical pharmacology of etoposide. Cancer 67:319","journal-title":"Cancer"},{"key":"CR20","first-page":"133","volume":"24","author":"DJ Stewart","year":"1983","unstructured":"Stewart DJ, Richard M, Hugenholtz H, Dennery J (1983) VP-16 (VP) and VM-26 (VM) penetration into human brain tumors (BT). Proc Am Assoc Cancer Res 24:133","journal-title":"Proc Am Assoc Cancer Res"},{"key":"CR21","first-page":"133","volume":"2","author":"DJ Stewart","year":"1984","unstructured":"Stewart DJ, Richard M, Hugenholtz H, Dennery JM, Belanger R, Gerin-Lajoie J, Montpetit V, Nundy D, Prior J, Hopkins HS (1984) Penetration of VP-16 (etoposide) into human intracerebral and extracerebral tumors. J Neurooncol 2:133","journal-title":"J Neurooncol"},{"key":"CR22","first-page":"2562","volume":"25","author":"S Takeda","year":"1990","unstructured":"Takeda S, Takada S, Kojima T, Kinoshita K, Sakamoto S (1990) Oral etoposide therapy in stage III?IV ovarian carcinoma. J Jpn Soc Cancer Ther 25:2562","journal-title":"J Jpn Soc Cancer Ther"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1200\/JCO.1984.2.5.432","volume":"2","author":"U Tirelli","year":"1984","unstructured":"Tirelli U, D'Incalci M, Canetta R, Tumolo S, Franchin G, Veronesi A, Galligiono E, Trovo MG, Rossi C, Grigoletto E (1984) Etoposide (VP-16-213) in malignant brain tumors: a phase II study. J Clin Oncol 2:432","journal-title":"J Clin Oncol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/0277-5379(88)90107-1","volume":"24","author":"P Viens","year":"1988","unstructured":"Viens P, Lagrange J-L, Thyss A, Ayela P Frenay M, Schneider M (1988) Brain metastases of lung cancer: excessive toxicity of high dose VP 16213. Eur J Cancer Clin Oncol 24:1905","journal-title":"Eur J Cancer Clin Oncol"},{"key":"CR25","first-page":"2651","volume":"16","author":"K Yuki","year":"1989","unstructured":"Yuki K, Kodama Y, Emoto K, Yukawa O, Onda J, Uozumi T (1989) A case report of advanced malignant mixed germ cell tumor of parasellar origin indicating marked efficacy of a salvage combined chemotherapy of CDDP and etoposide and subsequent chemotherapy using oral etoposide. Jpn J Cancer Chemother 16:2651","journal-title":"Jpn J Cancer Chemother"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00686001.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00686001\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00686001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T10:10:43Z","timestamp":1554459043000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00686001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1992]]}},"alternative-id":["BF00686001"],"URL":"https:\/\/doi.org\/10.1007\/bf00686001","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992]]}}}